Butterfly Network, Inc. (BFLY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Butterfly Network targets a 2026 Beam Steering API, opening core imaging to developers and enabling AI tools in Butterfly Garden.
Butterfly Network unveils Compass AI to streamline POCUS workflows, boosting documentation compliance and unlocking more revenue for health systems.
Butterfly Network, Inc. ( BFLY ) Q3 2025 Earnings Call October 31, 2025 8:00 AM EDT Company Participants Megan Carlson - Interim CFO, Chief Accounting Officer & Senior VP of Finance & Accounting Joseph DeVivo - CEO, President & Chairman of the Board Conference Call Participants Chase Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Joshua Jennings - TD Cowen, Research Division Andrew Brackmann - William Blair & Company L.L.C., Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Presentation Megan Carlson Interim CFO, Chief Accounting Officer & Senior VP of Finance & Accounting Good morning, and thank you for joining us.
Butterfly Network's Q3 loss widens but revenues top estimates, lifting shares as new AI tools and chip advances drive optimism.
Butterfly Network's Q3 earnings may have been shaped by iQ3 adoption, software growth and strategic progress.
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Public Service Enterprise Group, Genpact, The Progressive, Exelon and Butterfly Network.
BFLY trades at distressed levels with analyst targets signaling sharp upside, while TEM's premium valuation tempers its appeal.
Butterfly Network (BFLY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Butterfly Network, Inc. (NYSE:BFLY ) Q2 2025 Earnings Conference Call August 1, 2025 8:00 AM ET Company Participants Heather C. Getz - Executive VP, Chief Financial & Operations Officer and Corporate Secretary Joseph M.
Butterfly Network, Inc. (BFLY) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.05 per share a year ago.
BFLY outpaces TEM with stronger upside, leaner valuation, and expanding global reach in AI-powered diagnostics.